Pepcid ac and Bumetanide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pepcid ac and Bumetanide. Common interactions include chronic kidney disease among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people who take Pepcid ac and Bumetanide have. It is created by eHealthMe based on reports of 53 people who take Pepcid ac and Bumetanide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53 people who take Pepcid ac and Bumetanide together, and have interactions are studied.
What is Pepcid ac?
Pepcid ac has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,518 Pepcid ac users for its effectiveness, alternative drugs and more.
What is Bumetanide?
Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 17,318 Bumetanide users for its effectiveness, alternative drugs and more.
Number of Pepcid ac and Bumetanide reports submitted per year:
Common Pepcid Ac and Bumetanide drug interactions by gender *:
female:
- Chronic kidney disease
- Renal failure
- Renal injury
- Death
- Nephropathy
- Diarrhoea
- Tubulointerstitial nephritis
- Abdominal pain
- Acute respiratory failure
- Encephalopathy
male:
- Chronic kidney disease
- Renal failure
- Nephrogenic anaemia
- Pericardial effusion
- Pleural effusion
- Respiratory failure
- Splenomegaly
- Death
- Atelectasis
- Cardiac arrest
Common Pepcid Ac and Bumetanide drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Renal failure
- Tubulointerstitial nephritis
50-59:
- Chronic kidney disease
- Renal failure
- Renal injury
- Tubulointerstitial nephritis
- Death
- Diarrhoea
- Headache
- Nephrogenic anaemia
- Renal impairment
- Vomiting
60+:
- Chronic kidney disease
- Renal failure
- Nephrogenic anaemia
- Pain in extremity
- Pancreatic disorder
- Pneumonia
- Sepsis
- Cardiac arrest
- Hyperkalaemia
- Arthritis
Common conditions people have *:
- High Blood Pressure: 31 people, 58.49%
- High Blood Cholesterol: 23 people, 43.40%
- Pain: 20 people, 37.74%
- Cardiac Disorder: 12 people, 22.64%
- Depression: 11 people, 20.75%
- Infection: 11 people, 20.75%
- Diabetes: 9 people, 16.98%
- Blood Uric Acid Increased: 7 people, 13.21%
- Gastric Ulcer (stomach ulcer): 7 people, 13.21%
- Thyroid Diseases: 6 people, 11.32%
* Approximation only. Some reports may have incomplete information.
Do you take Pepcid ac and Bumetanide?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Pepcid ac (8,518 reports)
- Bumetanide (17,318 reports)
Browse all drug interactions of Pepcid ac and Bumetanide:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Pepcid ac side effects:
- Chronic kidney disease: 2,126 reports
- Acute kidney failure: 958 reports
- Drug ineffective: 821 reports
- Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 406 reports
- Headache (pain in head): 360 reports
- Fatigue (feeling of tiredness): 271 reports
Browse all side effects of Pepcid ac:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Bumetanide side effects:
- Breathing difficulty: 1,490 reports
- Fatigue (feeling of tiredness): 1,037 reports
- Death: 967 reports
- Acute kidney failure: 945 reports
- Chronic kidney disease: 854 reports
- Diarrhea: 831 reports
- Weakness: 823 reports
- Pneumonia: 791 reports
Browse all side effects of Bumetanide:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Pepcid ac interactions:
- Pepcid ac and Nexium: 2,202 reports
- Pepcid ac and Prilosec: 2,017 reports
- Pepcid ac and Prevacid: 1,933 reports
- Pepcid ac and Zantac: 1,768 reports
- Pepcid ac and Protonix: 1,725 reports
- Pepcid ac and Omeprazole: 1,517 reports
- Pepcid ac and Nexium 24hr: 1,310 reports
- Pepcid ac and Prevacid 24 hr: 1,117 reports
- Pepcid ac and Aspirin: 1,111 reports
- Pepcid ac and Pantoprazole: 1,103 reports
Browse all interactions between Pepcid ac and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Bumetanide interactions:
- Bumetanide and Aspirin: 3,445 reports
- Bumetanide and Spironolactone: 3,197 reports
- Bumetanide and Omeprazole: 2,812 reports
- Bumetanide and Allopurinol: 2,186 reports
- Bumetanide and Carvedilol: 2,041 reports
- Bumetanide and Lisinopril: 2,012 reports
- Bumetanide and Gabapentin: 1,935 reports
- Bumetanide and Furosemide: 1,838 reports
- Bumetanide and Simvastatin: 1,791 reports
- Bumetanide and Amlodipine: 1,784 reports
Browse all interactions between Bumetanide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on famotidine and bumetanide (the active ingredients of Pepcid ac and Bumetanide, respectively), and Pepcid ac and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pepcid ac and Bumetanide.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Kyprolis and Hydrochlorothiazide drug interaction - 15 seconds ago
- Dental Caries and Chills - 22 seconds ago
- Sustiva and Injection Site Haemorrhage - 22 seconds ago
- Peginterferon and Provigil drug interaction - 36 seconds ago
- Tagamet and Nexium drug interaction - 39 seconds ago
- Cephalexin and Fungal Nail Infection - 40 seconds ago
- Adefovir Dipivoxil and Heparin Sodium drug interaction - 40 seconds ago
- Jadelle and Facial Paralysis - 41 seconds ago
- Riboflavin and Limb Injury - 57 seconds ago
- Insomnia and Psychotic Behavior - a minute ago